SEMAWIN 0.5mg Injection

AboutSEMAWIN 0.5mg Injection contains Semaglutide, a GLP-1 receptor agonist for Type 2 diabetes management and weight loss.Usage Instructions: Inject subcutaneously once weekly as directed. Rotate injection sites (abdomen, thigh, upper arm). Follow pen device instructions carefully.Benefits: Improves blood sugar control, promotes significant weight loss, reduces cardiovascular risk, enhances insulin secretion, suppresses appetite.How it Works: Semaglutide mimics GLP-1 hormone, stimulating glucose-dependent insulin release, inhibiting glucagon, slowing gastric emptying, and promoting satiety.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions, fatigue.Safety Advice: Not for Type 1 diabetes or diabetic ketoacidosis. Inform doctor of thyroid cancer history, pancreatitis, or kidney disease. May cause thyroid C-cell tumors in rodents. Monitor for pancreatitis symptoms.Storage: Store refrigerated between 2-8°C. Do not freeze. After first use, may store at room temperature up to 30°C for 6 weeks. Keep pen cap on when not in use.